Publications by authors named "Ana Puljic Cuk"
Objective: We present a patient with metastatic melanoma who had a complete response to second line chemotherapy with paclitaxel and carboplatin.
Case Report: Metastatic melanoma is an aggressive cancer with poor prognosis and 10 year survival less than 10%. We present a patient with metastatic melanoma who had a complete response to second line chemotherapy with paclitaxel and carboplatin.